Neuronuclear and Neuromelanin‐Sensitive Imaging for Acquired Hepatocerebral Degeneration with Parkinsonism
- 11 February 2021
- journal article
- case report
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 8 (3) , 464-468
Abstract
No abstract availableKeywords
Funding Information
- Japan Agency for Medical Research and Development (JP20dm0307024)
- Japan Society for the Promotion of Science (19K17047)
This publication has 15 references indexed in Scilit:
- Cirrhosis-related Parkinsonism: Prevalence, mechanisms and response to treatmentsJournal of Hepatology, 2013
- Reduced Uptake of FDOPA PET in End-stage Liver Disease With Elevated Manganese LevelsArchives of Neurology, 2012
- Acquired hepatocerebral degeneration: clinical characteristics and MRI findingsEuropean Journal of Neurology, 2010
- Dopaminergic neuronal integrity in parkinsonism associated with liver cirrhosisNeuroToxicology, 2010
- Acquired hepatocerebral degenerationJournal of Neurology, 2009
- SPECT Follow-Up Study of Cerebral Blood Flow Changes During Donepezil Therapy in Patients with Alzheimer's DiseaseJournal of Neuroimaging, 2006
- [18F]FDOPA PET and clinical features in parkinsonism due to manganismMovement Disorders, 2005
- Distribution of divalent metal transporter-1 in the monkey basal gangliaNeuroscience, 2004
- Altered striatal dopamine D2 receptor density and dopamine transport in a patient with hepatic encephalopathyMetabolic Brain Disease, 2000
- Chronic acquired hepatocerebral degeneration: Case reports and new insightsMovement Disorders, 1995